NCCN Renal Cell Registry
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/24/2016 |
| Start Date: | March 2016 |
| End Date: | March 2018 |
| Contact: | Kerri Dalton |
| Email: | kerri.dalton@duke.edu |
| Phone: | 919-613-1391 |
Novel Educational Interventions for Community Oncologists & Patients: Optimizing Renal Cell Carcinoma Outcomes Through Engagement
This study will consist of three parts: 1) a retrospective chart review of patients treated
for mRCC from July 2013 until the start of the educational intervention; 2) an educational
program for DCN community oncology providers and DCN community patients with mRCC, lasting 8
- 10 months, and 3) a second retrospective chart review of patients treated for mRCC
starting at the time of the educational intervention until the intervention is completed.
for mRCC from July 2013 until the start of the educational intervention; 2) an educational
program for DCN community oncology providers and DCN community patients with mRCC, lasting 8
- 10 months, and 3) a second retrospective chart review of patients treated for mRCC
starting at the time of the educational intervention until the intervention is completed.
The initial retrospective cohort will serve as the pre-education control, and the second
cohort will be the experimental group to assess the efficacy of the educational intervention
to change care of patients with mRCC.
Chart Reviews. This study will begin with a multi-site chart review conducted at the Duke
Cancer Network affiliated sites. The chart review will begin in late fall, 2015. The Duke
Cancer Network team will perform chart abstraction for this study, with a goal of reviewing
at least 60 charts of patients treated between July 2013 and October 2015.
The second data collection period will collect data on patients with mRCC seen at DCN sites
after the date in fall 2015 when the educational intervention is rolled out. The target will
again be at least 60 charts of patients treated during the time the educational intervention
is actively available.
cohort will be the experimental group to assess the efficacy of the educational intervention
to change care of patients with mRCC.
Chart Reviews. This study will begin with a multi-site chart review conducted at the Duke
Cancer Network affiliated sites. The chart review will begin in late fall, 2015. The Duke
Cancer Network team will perform chart abstraction for this study, with a goal of reviewing
at least 60 charts of patients treated between July 2013 and October 2015.
The second data collection period will collect data on patients with mRCC seen at DCN sites
after the date in fall 2015 when the educational intervention is rolled out. The target will
again be at least 60 charts of patients treated during the time the educational intervention
is actively available.
Inclusion Criteria:
- Oncology providers (physicians, nurse practitioners, physicians' assistants) at DCN
affiliated sites will be invited to use the performance support system and
participate in the online virtual tumor boards for CME credit.
Exclusion Criteria:
- Non DCN affiliated sites providers
We found this trial at
1
site
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
